OMass Therapeutics

Series-B+
omass.com Biotech & Healthcare Oxford, United Kingdom Founded 2016 11-50
Total Funding $422.5M
Latest Round $310M Series-B+
Last Announced Oct 15, 2026
Investors 14 Backers
Decision Makers 6 Verified

About OMass Therapeutics

OMass Therapeutics is a drug discovery company exploiting novel mass spectrometry platforms to develop therapeutics.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-B+
Global Headquarters Oxford, United Kingdom
Year Founded 2016
Team Size 11-50
Tracked Since Oct 16, 2026

Web & Domain Identity

Official Website omass.com
Domain Registered Date Nov 2, 2013

Social & Network Presence

X / Twitter Profile @omasstx (596 followers) Created on Jun 2016
LinkedIn Corporate Company Profile

Company Milestones & Timeline

7 Events
  1. Capital Raise

    Raised $310,000,000 · Series-B

    Backed by Novo Holdings, GV

  2. Capital Raise

    Raised $12,510,000 · Series-B

    Backed by British Patient Capital

  3. Capital Raise

    Raised $100,000,000 · Series-B

    Backed by GV, Northpond Ventures

  4. Capital Raise

    Series-A announced

    Backed by Syncona Partners LLP, Oxford Science Enterprises

  5. Milestone

    X account created (@omasstx)

    596 followers

  6. Milestone

    Company founded

    Oxford, United Kingdom

  7. Milestone

    Website domain registered

    omass.com

Investors & Backers

14
Bain Capital Life Sciences
British Patient Capital
Forbion Capital Partners
GV
innovation.ox.ac.uk
Janus Henderson Investors
Jefferson Life Sciences
Northpond Ventures
Novo Holdings
Oxford Science Enterprises
Sanofi Ventures
SV Health Investors
Syncona Partners LLP
University of Oxford

Funding History

4 Rounds
Series-B equity · Oct 15, 2026

Round backers: Novo Holdings, GV, Janus Henderson Investors, Jefferson Life Sciences, Northpond Ventures, Oxford Science Enterprises, Sanofi Ventures, SV Health Investors, Syncona Partners LLP, University of Oxford

$310,000,000 biotechtv.com
Series-B equity · May 15, 2023

Round backers: British Patient Capital

$12,510,000 lnkd.in
Series-B equity · Apr 28, 2022

Round backers: GV, Northpond Ventures, Sanofi Ventures, Oxford Science Enterprises, Syncona Partners LLP, University of Oxford

$100,000,000 omass.com
Series-A equity · Feb 17, 2020

Round backers: Syncona Partners LLP, Oxford Science Enterprises, innovation.ox.ac.uk

Undisclosed

Founders & Leadership

6

Hsin-Yung Yen

Founder

Work email & phone locked Unlock →

Idlir Liko

Founder

Work email & phone locked Unlock →

Jonathan Hopper

Founder

Work email & phone locked Unlock →

Jon Roffey

VP, Head of Medicinal Chemistry

Work email & phone locked Unlock →

Melissa Faris

Chief Business Officer

Work email & phone locked Unlock →

Ros Deegan

CEO

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts